AR049073A1 - Polimorfos cristalinos de (3s)-n-hidroxi-4-({4-[(4-hidroxi-2-butinil)oxi]fenil}sulfonil)-2,2-dimetil-3-tiomorfolina carboxamida - Google Patents

Polimorfos cristalinos de (3s)-n-hidroxi-4-({4-[(4-hidroxi-2-butinil)oxi]fenil}sulfonil)-2,2-dimetil-3-tiomorfolina carboxamida

Info

Publication number
AR049073A1
AR049073A1 ARP050102315A ARP050102315A AR049073A1 AR 049073 A1 AR049073 A1 AR 049073A1 AR P050102315 A ARP050102315 A AR P050102315A AR P050102315 A ARP050102315 A AR P050102315A AR 049073 A1 AR049073 A1 AR 049073A1
Authority
AR
Argentina
Prior art keywords
hidroxi
sulfonyl
dimethyl
phenyl
crystalline
Prior art date
Application number
ARP050102315A
Other languages
English (en)
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of AR049073A1 publication Critical patent/AR049073A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/12—1,4-Thiazines; Hydrogenated 1,4-thiazines not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Polimorfos cristalinos de (3S)-N-hidroxi-4-({4-[(4-hidroxi-2-butinil)oxi]fenil}sulfonil)-2,2-dimetil-3-tiomorfolina carboxamida, métodos de preparacion y usos. Reivindicacion 1: Un polimorfo cristalino de (3S)-N-hidroxi-4-({4-[(4-hidroxi-2- butinil)oxi]fenil}sulfonil)-2,2-dimetil-3-tiomorfolina carboxamida, que tiene un patron de difraccion de rayos X de polvo que comprende picos, en ángulo de difraccion q, de aproximadamente 7.5s; 19.6s; 24.7s; y 26.2s
ARP050102315A 2004-06-08 2005-06-07 Polimorfos cristalinos de (3s)-n-hidroxi-4-({4-[(4-hidroxi-2-butinil)oxi]fenil}sulfonil)-2,2-dimetil-3-tiomorfolina carboxamida AR049073A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57778404P 2004-06-08 2004-06-08

Publications (1)

Publication Number Publication Date
AR049073A1 true AR049073A1 (es) 2006-06-21

Family

ID=35106941

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP050102314A AR049349A1 (es) 2004-06-08 2005-06-07 Metodo para la preparacion de acidos hidroxamicos
ARP050102315A AR049073A1 (es) 2004-06-08 2005-06-07 Polimorfos cristalinos de (3s)-n-hidroxi-4-({4-[(4-hidroxi-2-butinil)oxi]fenil}sulfonil)-2,2-dimetil-3-tiomorfolina carboxamida

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP050102314A AR049349A1 (es) 2004-06-08 2005-06-07 Metodo para la preparacion de acidos hidroxamicos

Country Status (6)

Country Link
US (2) US7179911B2 (es)
AR (2) AR049349A1 (es)
GT (1) GT200500139A (es)
PA (2) PA8636301A1 (es)
TW (2) TW200610523A (es)
WO (2) WO2005123706A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2383525T3 (es) 2003-11-05 2012-06-21 Sarcode Bioscience Inc. Moduladores de la adhesión celular
GT200500139A (es) * 2004-06-08 2005-07-25 Metodo para la preparacion de acidos hidroxamicos
CA2609053C (en) 2005-05-17 2017-04-25 Sarcode Corporation Compositions and methods for treatment of eye disorders
FR2898497B1 (fr) * 2006-03-20 2008-05-16 Galderma Res & Dev Utilisation de l'apratastat ou du (s)-n-hydroxy-4-(4-but-2- ynyloxy-benzenesulfonyl)-2,2-dimethyl-thiomorpholine-3-carbo xamide dans le traitement de pathologies inflammatoires cutanees
US7631568B2 (en) * 2007-08-28 2009-12-15 Quest Technologies Particulate monitor
EP3797775A1 (en) 2007-10-19 2021-03-31 Novartis AG Compositions and methods for treatment of diabetic retinopathy
WO2009139817A2 (en) * 2008-04-15 2009-11-19 Sarcode Corporation Crystalline pharmaceutical and methods of preparation and use thereof
US8378105B2 (en) 2009-10-21 2013-02-19 Sarcode Bioscience Inc. Crystalline pharmaceutical and methods of preparation and use thereof
CA2779711C (en) 2009-11-06 2016-11-01 Forest Laboratories Holding Limited Novel crystalline forms of (1s,2r)-2-(amino methyl)-n,n-diethyl-1-phenyl cyclopropane carboxamide
MX2015001098A (es) 2012-07-25 2015-09-25 Sarcode Bioscience Inc Inhibidor del antigeno-1 asociado a la funcion del linfocito (lfa-1) y polimorfo del mismo.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0874830T3 (da) * 1995-12-08 2003-04-22 Agouron Pharma Metalloproteinaseinhibitor, farmaceutisk præparat indeholdende denne og den farmaceutiske anvendelse samt en fremgangsmåde til fremstilling deraf
EP0960098A1 (en) * 1997-02-11 1999-12-01 Pfizer Inc. Arylsulfonyl hydroxamic acid derivatives
US6225311B1 (en) * 1999-01-27 2001-05-01 American Cyanamid Company Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitors
US6387901B1 (en) * 1999-07-06 2002-05-14 Pfizer Inc Alkyne containing metalloproteinase inhibitors
CA2357110A1 (en) * 2001-04-11 2002-10-11 American Cyanamid Company Method for the treatment of polycystic kidney disease
BR0213736A (pt) 2001-11-01 2004-10-19 Wyeth Corp ácidos hidroxâmicos de sulfonamida de arila alênica como metaloproteinase matriz e inibidores de tace
GT200500139A (es) * 2004-06-08 2005-07-25 Metodo para la preparacion de acidos hidroxamicos

Also Published As

Publication number Publication date
WO2005123706A1 (en) 2005-12-29
US20050272929A1 (en) 2005-12-08
TW200612959A (en) 2006-05-01
US7179911B2 (en) 2007-02-20
TW200610523A (en) 2006-04-01
GT200500139A (es) 2005-07-25
PA8636301A1 (es) 2006-03-24
AR049349A1 (es) 2006-07-19
WO2005123706A9 (en) 2006-04-27
US20050272928A1 (en) 2005-12-08
WO2005123705A1 (en) 2005-12-29
US7435732B2 (en) 2008-10-14
PA8636101A1 (es) 2006-03-24

Similar Documents

Publication Publication Date Title
AR049073A1 (es) Polimorfos cristalinos de (3s)-n-hidroxi-4-({4-[(4-hidroxi-2-butinil)oxi]fenil}sulfonil)-2,2-dimetil-3-tiomorfolina carboxamida
ATE377589T1 (de) 6-substituierte nikotinamidderivate als opioidrezeptorantagonisten
ATE397605T1 (de) Nebivolol und dessen pharmazeutisch unbedenkliche salze, herstellungsverfahren und pharmazeutische zusammensetzungen von nebivolol
DK1503785T3 (da) Nye vævsfaktor targeted thrombomodklin-fusions-proteiner som antikoagulanter
DE60130771D1 (de) Substituierte heterocyclische amide
NO20061153L (no) Trans-1-(6-klor-3-fenylindan-1-yl)-3,3-dimetylpiperazin
NO20052928D0 (no) Nye kjemiske forbindelser
HK1165426A1 (en) Methods of synthesizing pharmaceutical salts of a factor xa inhibitor xa
DE60333607D1 (de) Chirurgische Klammervorrichtung
DE60236767D1 (de) Medizinische Verwendung eines TetrahydrotriazoloÄ4,3-aÜpyrazins
NO20054005D0 (no) Nye arylpiperazinylforbindelser
ATE428701T1 (de) Kristalline form von bisä(e)-7-ä4-(4-fluorphenyl)-6-isopropyl-2-
DE602005008402D1 (de) Stereoselektive synthese bestimmter trifluormethylsubstituierter alkohole
ATE475640T1 (de) Antagonisten des opioidrezeptors
NO20045486L (no) Nye forbindelser og deres anvendelse
EP2189439A3 (en) CaSR antagonist
NO20033679L (no) Nye pyrimidinforbindelser
DK1511489T3 (da) Nye farmaceutiske sammensætninger indeholdende flibanserin-polymorf A
EA200800324A1 (ru) Новый способ получения солей тиотропия
DE60319080D1 (de) Phenyloxyalkansäure-derivate als hppar aktivatore
FR2894578B1 (fr) Derives heterocycliques, leur preparation et leur application en therapeutique.
EA200600898A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
NO20053910L (no) Nye piperazinderivater og deres anvendelse som syntesemellomprodukter.
FR2894579B1 (fr) Derives diaryltriazolmethylamine, leur preparation et leur application en therapeutique.
EA200501900A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей

Legal Events

Date Code Title Description
FB Suspension of granting procedure